Status:
COMPLETED
Mirena Efficiency and Tolerability During the First Year of Use
Lead Sponsor:
Bayer
Conditions:
Medicated Intrauterine Devices
Contraception
Eligibility:
FEMALE
25-39 years
Phase:
PHASE4
Brief Summary
In this trial the efficacy and safety of Mirena was investigated during the first year of use
Eligibility Criteria
Inclusion
- Women aged 25 to 39 years who sought effective contraception during the post-partum period (i.e. insertion of the device between 6 and 12 weeks after parturition).
Exclusion
- Standard exclusion criteria for use of intrauterine hormone devices
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2005
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT00696202
Start Date
September 1 2003
End Date
March 1 2005
Last Update
December 31 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amiens, France, 80054